{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:54:47Z","timestamp":1792212887034,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"23-24","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.drudis.2013.08.005","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T13:47:44Z","timestamp":1377006464000},"page":"1272-1281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Novel therapeutic strategies for treatment of visceral leishmaniasis"],"prefix":"10.1016","volume":"18","author":[{"given":"Keerti","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2013.08.005_bib0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pt.2012.03.001","article-title":"Neglected tropical diseases and mental health: a perspective on comorbidity","volume":"28","author":"Litt","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0010","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.exppara.2010.09.003","article-title":"Immunomodulatory effect of picroliv on the efficacy of paromomycin and miltefosine in combination in experimental visceral leishmaniasis","volume":"127","author":"Sane","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molbiopara.2011.08.006","article-title":"IMP dehydrogenase deficiency in Leishmania donovani causes a restrictive growth phenotype in promastigotes but is not essential for infection in mice","volume":"180","author":"Fulwiler","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0020","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jhep.2011.05.039","article-title":"Nanotechnology for therapy and imaging of liver diseases","volume":"55","author":"Reddy","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.nano.2011.07.002","article-title":"Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery","volume":"8","author":"Singodia","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.drudis.2013.08.005_bib0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.idc.2012.03.005","article-title":"Visceral leishmaniasis","volume":"26","author":"van Griensven","year":"2012","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.drudis.2013.08.005_bib0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.imbio.2012.02.008","article-title":"115kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-(induced down-regulation of TNF-\u03b1 mediated MMP-9 activity","volume":"218","author":"Choudhury","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.drudis.2013.08.005_bib0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.chom.2011.03.011","article-title":"Imaging host cell-Leishmania interaction dynamics implicates parasite motility, lysosome recruitment, and host cell wounding in the infection process","volume":"9","author":"Forestier","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2013.08.005_bib0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pt.2011.04.001","article-title":"Urban parasitology: visceral leishmaniasis in Brazil","volume":"27","author":"Harhay","year":"2011","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0050","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.drudis.2013.08.005_bib0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pt.2010.12.003","article-title":"The fitness of antimony-resistant Leishmania parasites: lessons from the field","volume":"27","author":"Ait-Oudhia","year":"2011","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0060","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.intimp.2012.02.002","article-title":"Miltefosine triggers a strong proinflammatory cytokine response during visceral leishmaniasis: Role of TLR4 and TLR9","volume":"12","author":"Mukherjee","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0065","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.exppara.2010.10.014","article-title":"Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India","volume":"127","author":"Singh","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejmech.2012.04.029","article-title":"Discovery of a new antileishmanial hit in 8-nitroquinoline series","volume":"54","author":"Paloque","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drudis.2013.08.005_bib0075","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.bmcl.2011.12.101","article-title":"Synthesis and antikinetoplastid activity of a series of N,N\u2032-substituted diamines","volume":"22","author":"Caminos","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2013.08.005_bib0080","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijantimicag.2012.01.003","article-title":"In vitro evaluation of bisnaphthalimidopropyl derivatives loaded into pegylated nanoparticles against Leishmania infantum protozoa","volume":"39","author":"Lima","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.drudis.2013.08.005_bib0085","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.parint.2011.11.005","article-title":"Anti-leishmanial activity of the bisnaphthalimidopropyl derivatives","volume":"61","author":"Tavares","year":"2012","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.drudis.2013.08.005_bib0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exppara.2012.01.010","article-title":"Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi","volume":"130","author":"Reimao","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0095","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1016\/j.bmcl.2012.06.037","article-title":"Antileishmanial bis-arylimidamides: DB766 analogs modified in the linker region and bis-arylimidamide structure\u2013activity relationships","volume":"22","author":"Reid","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2013.08.005_bib0100","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.bmcl.2011.01.101","article-title":"Potent antiprotozoal activity of a novel semi-synthetic berberine derivative","volume":"21","author":"Bahar","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2013.08.005_bib0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np300638f","article-title":"8,8-Dialkyldihydroberberines with potent antiprotozoal activity","volume":"76","author":"Endeshaw","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.drudis.2013.08.005_bib0110","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/jac\/dkq371","article-title":"Mechanism of interaction of sitamaquine with Leishmania donovani","volume":"65","author":"Coimbra","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2013.08.005_bib0115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.peptides.2011.01.011","article-title":"Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells","volume":"32","author":"Perez-Cordero","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.drudis.2013.08.005_bib0120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.toxicon.2011.04.018","article-title":"A comparative study of the effects of venoms from five rear-fanged snake species on the growth of Leishmania major: identification of a protein with inhibitory activity against the parasite","volume":"58","author":"Peichoto","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.drudis.2013.08.005_bib0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exppara.2011.02.021","article-title":"In vitro and experimental therapeutic studies of the calcium channel blocker bepridil: detection of viable Leishmania (L.) chagasi by real-time PCR","volume":"128","author":"Reimao","year":"2011","journal-title":"Exp. Parasitol."},{"issue":"E1612","key":"10.1016\/j.drudis.2013.08.005_bib0130","first-page":"1","article-title":"In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and sbv-resistant parasites","volume":"6","author":"Varela-M","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.drudis.2013.08.005_bib0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.colsurfb.2013.01.061","article-title":"One pot synthesis of gold nanoparticles and application in chemotherapy of wild and resistant type visceral leishmaniasis","volume":"107","author":"Das","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.drudis.2013.08.005_bib0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bcmd.2007.06.008","article-title":"Albumin\u2013quercetin combination offers a therapeutic advantage in the prevention of reduced survival of erythrocytes in visceral leishmaniasis","volume":"39","author":"Sen","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.drudis.2013.08.005_bib0145","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jep.2011.01.044","article-title":"Deciphering molecular mechanism underlying antileishmanial activity of Nyctanthes arbortristis, an Indian medicinal plant","volume":"134","author":"Shukla","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2011.08.016","article-title":"PLGA nanoparticles loaded with the antileishmanial saponin \u03b2-aescin: factor influence study and in vitro efficacy evaluation","volume":"420","author":"Van de Ven","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2013.08.005_bib0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.vetpar.2011.01.007","article-title":"In vitro effect of Aloe vera, Coriandrum sativum and Ricinus communis fractions on Leishmania infantum and on murine monocytic cells","volume":"178","author":"Rondon","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.exppara.2012.07.005","article-title":"Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis","volume":"132","author":"Valadares","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0165","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s00436-013-3387-2","article-title":"Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis","volume":"112","author":"Sachdeva","year":"2013","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.drudis.2013.08.005_bib0170","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/14786419.2012.696254","article-title":"An antileishmanial prenyloxy-naphthoquinone from roots of plumbago zeylanica","volume":"27","author":"Mishra","year":"2013","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.drudis.2013.08.005_bib0175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.phymed.2012.11.013","article-title":"Leishmanicidal activity assessment of olive tree extracts","volume":"20","author":"Kyriazis","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.drudis.2013.08.005_bib0180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jconrel.2012.04.004","article-title":"The efficacy of aerosol treatment with non-ionic surfactant vesicles containing AmB in rodent models of leishmaniasis and pulmonary aspergillosis infection","volume":"160","author":"Alsaadi","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2013.08.005_bib0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/17425247.2013.751370","article-title":"Targeted drug delivery to macrophages","volume":"10","author":"Jain","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.drudis.2013.08.005_bib0190","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1016\/j.biomaterials.2012.02.033","article-title":"A review of glycosylated carriers for drug delivery","volume":"33","author":"Jain","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2013.08.005_bib0195","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003495-200969030-00010","article-title":"Liposomal AmB a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections","volume":"69","author":"Moen","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.drudis.2013.08.005_bib0200","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1128\/AAC.48.9.3246-3252.2004","article-title":"Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres","volume":"48","author":"Sanchez-Brunete","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2013.08.005_bib0205","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/02652048.2011.559281","article-title":"Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis","volume":"28","author":"Kunjachan","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.drudis.2013.08.005_bib0210","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s11095-009-9973-4","article-title":"Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles","volume":"26","author":"Nahar","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2013.08.005_bib0215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/10611860903115290","article-title":"In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis","volume":"18","author":"Nahar","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.drudis.2013.08.005_bib0220","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/jac\/dkr002","article-title":"Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes","volume":"66","author":"Prajapati","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2013.08.005_bib0225","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/1061186X.2012.697168","article-title":"Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes","volume":"20","author":"Pruthi","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.drudis.2013.08.005_bib0230","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.exppara.2012.04.007","article-title":"Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection","volume":"131","author":"Bimal","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0235","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.exppara.2012.05.007","article-title":"Enhancement in therapeutic efficacy of miltefosine in combination with synthetic bacterial lipopeptide, Pam2Cys against experimental Visceral Leishmaniasis","volume":"131","author":"Shakya","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0240","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drudis.2013.08.005_bib0245","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomized controlled trial","volume":"377","author":"Sundar","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2013.08.005_bib0250","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2012.698189","article-title":"Structure prediction of gBP21 protein of L. donovani and its molecular interaction","author":"Sahoo","year":"2013","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.drudis.2013.08.005_bib0255","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1473-3099(10)70320-0","article-title":"Visceral leishmaniasis: elimination with existing interventions","volume":"11","author":"Matlashewski","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drudis.2013.08.005_bib0260","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0140-6736(10)62237-4","article-title":"Combination therapy for visceral leishmaniasis","volume":"377","author":"van Griensven","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2013.08.005_bib0265","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jac\/dkn046","article-title":"Oral therapy with sertraline, a selective serotonin reuptake inhibitor, shows activity against Leishmania donovani","volume":"61","author":"Palit","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2013.08.005_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/756568","article-title":"In vitro antiparasitic and apoptotic effects of antimony sulfide nanoparticles on Leishmania infantum","volume":"756568","author":"Soflaei","year":"2012","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.drudis.2013.08.005_bib0275","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.chemphyslip.2013.05.002","article-title":"Recent developments in the antiprotozoal and anticancer activities of the 2-alkynoic fatty acids","volume":"172C\u2013173C","author":"Carballeira","year":"2013","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.drudis.2013.08.005_bib0280","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1099\/jmm.0.47114-0","article-title":"Racemoside A, an anti-leishmanial, water-soluble, natural steroidal saponin, induces programmed cell death in Leishmania donovani","volume":"56","author":"Dutta","year":"2007","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0285","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1099\/jmm.0.009290-0","article-title":"Pro-apoptotic effect of the landrace Bangla Mahoba of Piper betle on Leishmania donovani may be due to the high content of eugenol","volume":"58","author":"Misra","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.drudis.2013.08.005_bib0290","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nano.2008.03.007","article-title":"Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles","volume":"4","author":"Nahar","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.drudis.2013.08.005_bib0295","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/dta.389","article-title":"Paromomycin-loaded albumin microspheres: efficacy and stability studies","volume":"5","author":"Khan","year":"2013","journal-title":"Drug Test. Anal."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644613002687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644613002687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:18:06Z","timestamp":1761221886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644613002687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":59,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1359644613002687"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2013.08.005","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel therapeutic strategies for treatment of visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2013.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}